Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample.
- Authors
- Peer, Kyle; Rennert, Lior; Lynch, Kevin G; Farrer, Lindsay; Gelernter, Joel; Kranzler, Henry R
- Year
- 2013
- Journal
- Drug and alcohol dependence
- PMID
- 22884164
- DOI
- 10.1016/j.drugalcdep.2012.07.009
- PMCID
- PMC3727225
BACKGROUND: The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) will soon replace the DSM-IV, which has existed for nearly two decades. The changes in diagnostic criteria have important implications for research and for the clinical care of individuals with Substance Use Disorders (SUDs). METHODS: We used the Semi-Structured Assessment for Drug Dependence and Alcoholism to evaluate the lifetime presence of DSM-IV abuse and dependence diagnoses and DSM-5 mild, moderate, or severe SUDs for alcohol, cocaine, opioids, and cannabis in a sample of 7,543 individuals recruited to participate in genetic studies of substance dependence. RESULTS: Switches between diagnostic systems consistently resulted in a modestly greater prevalence for DSM-5 SUDs, based largely on the assignment of DSM-5 diagnoses to DSM-IV "diagnostic orphans" (i.e., individuals meeting one or two criteria for dependence and none for abuse, and thus not receiving a DSM-IV SUD diagnosis). The vast majority of these diagnostic switches were attributable to the requirement that only two of 11 criteria be met for a DSM-5 SUD diagnosis. We found evidence to support the omission from DSM-5 of the legal criterion due to its limited diagnostic utility. The addition of craving as a criterion in DSM-5 did not substantially affect the likelihood of an SUD diagnosis. CONCLUSION: The greatest advantage of DSM-5 for the diagnosis of SUDs appears to be its ability to capture diagnostic orphans. In this sample, changes reflected in DSM-5 had a minimal impact on the prevalence of SUD diagnoses.
No figures extracted from this document.
| Name | Type |
|---|---|
| abuse criterion local | phenotype |
| affected cases local | cohort |
| Agrawal et al. (2011) local | cohort |
| Agrawal et al. 2011 local | cohort |
| Agrawal et al., 2011 local | cohort |
| alcohol | phenotype |
| alcohol abuse | phenotype |
| alcohol dependence | phenotype |
| Alcohol Use Disorder | phenotype |
| alcohol use disorders | phenotype |
| Alcohol use severity continuum local | phenotype |
| amphetamine | drug |
| Amphetamine use disorder | phenotype |
| any SUD local | phenotype |
| Boscarino et al. 2011 local | cohort |
| cannabis use | phenotype |
| cannabis use disorder | phenotype |
| case-control sample | cohort |
| chronic pain | phenotype |
| cocaine | phenotype |
| cocaine disorder local | phenotype |
| cocaine use disorder | phenotype |
| Cocaine use disorders local | phenotype |
| college students | cohort |
| control subjects | cohort |
| craving | phenotype |
| Dependence symptoms | phenotype |
| diagnostic orphans | phenotype |
| Driving while intoxicated local | phenotype |
| drug dependence | phenotype |
| DSM-5 mild SUD local | phenotype |
| DSM-5 moderate or severe SUD local | phenotype |
| DSM-5 moderate SUD local | phenotype |
| DSM-5 severe SUD local | phenotype |
| DSM-IV | phenotype |
| DSM-IV abuse diagnosis local | phenotype |
| DSM-IV abuse or dependence local | phenotype |
| DSM-IV diagnostic orphan local | phenotype |
| DSM-IV substance abuse local | phenotype |
| full sample | cohort |
| Hasin et al. (2012) local | cohort |
| hazardous drinking | phenotype |
| hazardous use | phenotype |
| hazardous use criterion local | phenotype |
| heavy drinking | phenotype |
| Help-seeking behavior local | phenotype |
| Keyes et al. (2011) local | cohort |
| large SUD cohort local | cohort |
| legal criterion | phenotype |
| legal problems | phenotype |
| McLean Hospital | cohort |
| Medical University of South Carolina | cohort |
| Mewton et al. 2010 local | cohort |
| Mewton et al. (2011) local | cohort |
| Mewton et al. 2011 local | cohort |
| Moderate SUD local | phenotype |
| no SUD local | phenotype |
| opioid | drug |
| opioid dependence | phenotype |
| opioid disorder local | phenotype |
| Other 11 criteria local | phenotype |
| other criteria local | phenotype |
| population studies | cohort |
| Prescription drug local | drug |
| Prescription drug use disorder local | phenotype |
| present study | cohort |
| Proctor et al. 2012 local | cohort |
| proposed DSM-5 criteria changes local | phenotype |
| Severe SUD local | phenotype |
| Shmulewitz et al. (2010) local | cohort |
| SSADDA local | cohort |
| State prison inmates local | cohort |
| substance | phenotype |
| substance use | phenotype |
| Substance Use Disorder diagnoses local | phenotype |
| SUD diagnosis local | phenotype |
| SUD prevalence local | phenotype |
| trauma | phenotype |
| University of Connecticut Health Center | cohort |
| University of Pennsylvania | cohort |
| Yale University School of Medicine | cohort |
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A Systematic Review and Meta-Analysis of Dual Diagnosis Patient Profile in the Clinical Setting. | Choudhary H et al. | β | 2025 | β |
| The association of cognitive functioning and substance use disorders with adaptive impairments of inpatients in forensic addiction treatment. | Suelmann R et al. | β | 2025 | β |
| Application of polygenic scores to a deeply phenotyped sample enriched for substance use disorders reveals extensive pleiotropy with psychiatric and somatic traits. | Hartwell EE et al. | β | 2024 | β |
| Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004-2019. | Mauro PM et al. | β | 2024 | β |
| Higher Prevalence Estimates of Substance Use Disorders With DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use: The Role of DSM-IV Diagnostic Orphans. | Hasin D et al. | β | 2024 | β |
| Assessing the diagnostic utility of the Cannabis Use Disorder Identification Test - Revised (CUDIT-R) among veterans with medical and non-medical cannabis use. | Myers MG et al. | β | 2023 | β |
| Phenome-wide Association Analysis of Substance Use Disorders in a Deeply Phenotyped Sample. | Kember RL et al. | β | 2023 | β |
| Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non-Clinicians. | Di Paola A et al. | β | 2023 | β |
| A Brief Screening Tool for Opioid Use Disorder: EMPOWER Study Expert Consensus Protocol. | You DS et al. | β | 2021 | β |
| Agreement between DSM-5 and DSM-IV measures of substance use disorders in a sample of adult substance users. | Livne O et al. | β | 2021 | β |
| Cannabis Abuse and Perioperative Complications Following Inpatient Spine Surgery in the United States. | Chiu RG et al. | β | 2021 | β |
| Comorbid Substance Use Disorder Profiles and Receipt of Substance Use Disorder Treatment Services: A National Study. | Von Gunten CD et al. | β | 2021 | β |
| Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse. | Lagisetty P et al. | β | 2021 | β |
| Inhibitory failures in cocaine use disorder: Not paying attention when there is a need to be cautious. | Howlett JR et al. | β | 2021 | β |
| Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis. | Kowalec K et al. | β | 2021 | β |
| Agreement between DSM-IV and DSM-5 measures of substance use disorders in a sample of adult substance users | Livne O et al. | β | 2020 | β |
| Blockade of Orexin Receptors in the Posterior Paraventricular Nucleus of the Thalamus Prevents Stress-Induced Reinstatement of Reward-Seeking Behavior in Rats With a History of Ethanol Dependence. | Matzeu A et al. | β | 2020 | β |
| Receiving addiction treatment in the US: Do patient demographics, drug of choice, or substance use disorder severity matter? | Johnson K et al. | β | 2020 | β |
| Treatment Of Opioid Use Disorder Among Commercially Insured US Adults, 2008-17. | Shen K et al. | β | 2020 | β |
| An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use. | Budney AJ et al. | β | 2019 | β |
| Cannabis use disorders among adults in the United States during a time of increasing use of cannabis. | Compton WM et al. | β | 2019 | β |
| Severity of Substance Use Disorder: Utility as an Outcome in Clinical Settings. | Dacosta-SΓ‘nchez D et al. | β | 2019 | β |
| Sexual orientation and gender identity disparities in substance use disorders during young adulthood in a United States longitudinal cohort. | Jun HJ et al. | β | 2019 | β |
| Characterizing a Hidden Group of At-Risk Drinkers: Epidemiological Profiles of Alcohol-Use Disorder Diagnostic Orphans. | Gilbert PA et al. | β | 2018 | β |
| Exploring Sex Differences in the Attenuation of Ethanol Drinking by Naltrexone in Dependent Rats During Early and Protracted Abstinence. | Matzeu A et al. | β | 2018 | β |
| Falling rates of marijuana dependence among heavy users. | Davenport S | β | 2018 | β |
| Intensity of Daily Drinking and Its Relation to Alcohol Use Disorders. | VergΓ©s A et al. | β | 2018 | β |
| Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana. | Richter L et al. | β | 2017 | β |
| Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians. | Copeland WE et al. | β | 2017 | β |
| Comparison of DSM-IV and DSM-5 criteria for alcohol use disorders in VA primary care patients with frequent heavy drinking enrolled in a trial. | Takahashi T et al. | β | 2017 | β |
| Foods are differentially associated with subjective effect report questions of abuse liability. | Schulte EM et al. | β | 2017 | β |
| Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014. | Martins SS et al. | β | 2017 | β |
| Is General or Alcohol-Specific Perceived Social Support Associated with Depression among Adults in Substance Use Treatment? | Shorey RC et al. | β | 2016 | β |
| Subthreshold problem drinkers in DSM-5 alcohol use disorder classification. | Baggio S et al. | β | 2016 | β |
| Which alcohol use disorder criteria contribute to the association of ADH1B with alcohol dependence? | Hart AB et al. | β | 2016 | β |
| From DSM-IV to DSM-5 alcohol use disorder: an overview of epidemiological data. | Bartoli F et al. | β | 2015 | β |
| Inter-observer reliability of DSM-5 substance use disorders. | Denis CM et al. | β | 2015 | β |
| Latent class analysis of DSM-5 criteria for opioid use disorders: results from the Iranian National Survey on Mental Health. | Tarrahi MJ et al. | β | 2015 | β |
| Memantine reduces alcohol drinking but not relapse in alcohol-dependent rats. | Alaux-Cantin S et al. | β | 2015 | β |
| Nosologic Comparisons of DSM-IV and DSM-5 Alcohol and Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. | Goldstein RB et al. | β | 2015 | β |
| The association between at-risk gambling and binge drinking in the general Swedish population. | Sundqvist K et al. | β | 2015 | β |
| Childhood maltreatment, stressful life events, and alcohol craving in adult drinkers. | Kim JH et al. | β | 2014 | β |
| Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients. | Kelly SM et al. | β | 2014 | β |
| Craving as an alcohol use disorder symptom in DSM-5: an empirical examination in a treatment-seeking sample. | Murphy CM et al. | β | 2014 | β |
| DSM-5 alcohol use disorder criteria in "Crazy Heart" (2009)-a media content analysis with teaching purposes. | da Silva RD et al. | β | 2014 | β |
| DSM-5 cannabis use disorder: a phenotypic and genomic perspective. | Agrawal A et al. | β | 2014 | β |
| DSM-5 gambling disorder: prevalence and characteristics in a substance use disorder sample. | Rennert L et al. | β | 2014 | β |
| DSM-5 latent classes of alcohol users in a population-based sample: results from the SΓ£o Paulo Megacity Mental Health Survey, Brazil. | Castaldelli-Maia JM et al. | β | 2014 | β |
| Operant alcohol self-administration in dependent rats: focus on the vapor model. | Vendruscolo LF et al. | β | 2014 | β |
| Prevalence of alcohol dependence among US adult drinkers, 2009-2011. | Esser MB et al. | β | 2014 | β |
| Psychobiology of cocaine addiction: Contribution of a multi-symptomatic animal model of loss of control. | Deroche-Gamonet V et al. | β | 2014 | β |
| The liberating dimension of human habit in addiction context. | GΓΌell F et al. | β | 2014 | β |
| A multistep general theory of transition to addiction. | Piazza PV et al. | β | 2013 | β |
| DSM-5 criteria for substance use disorders: recommendations and rationale. | Hasin DS et al. | β | 2013 | β |
| Epidemiology of alcohol and drug use in the elderly. | Wang YP et al. | β | 2013 | β |